
U.S. Officials Express Optimism Over New CDC Director Selection Amid Vaccine Policy Turmoil
Mar 20, 2026 02:46 am UTC| Governance Politics Health
The United States is moving closer to naming a permanent leader for the Centers for Disease Control and Prevention, according to a top health official. Chris Klomp, chief counselor at the Department of Health and Human...

FDA Biologics Chief Vinay Prasad to Leave Agency in April Amid Policy Disputes
Mar 07, 2026 05:05 am UTC| Health Governance Business
Dr. Vinay Prasad, the controversial director of the U.S. Food and Drug Administrations Center for Biologics Evaluation and Research (CBER), will step down from his role at the end of April, according to FDA Commissioner...

FDA Warns Novo Nordisk Over Misleading Ozempic Ad Claims
Mar 04, 2026 01:16 am UTC| Business Health Governance
The U.S. Food and Drug Administration (FDA) has issued a warning to Danish pharmaceutical giant Novo Nordisk regarding a consumer advertisement for its widely used diabetes drug, Ozempic. According to the regulator, the ad...

Moderna to Pay Up to $2.25B to Settle LNP Patent Dispute Over COVID-19 Vaccine Technology
Mar 04, 2026 01:01 am UTC| Business Health Law
Moderna has reached a major legal settlement worth up to $2.25 billion with Genevant Sciences and Arbutus Biopharma, ending a long-running patent dispute over the lipid nanoparticle (LNP) technology used in its COVID-19...

CDC Acting Director Urges Measles Vaccination as U.S. Cases Surge in 2026
Mar 03, 2026 01:29 am UTC| Governance Health
The U.S. Centers for Disease Control and Prevention (CDC) is reinforcing its message that measles vaccination remains the most effective protection against the highly contagious disease, as cases climb to their highest...

Democratic Attorneys General Sue Trump Administration Over CDC Childhood Vaccine Schedule Changes
Feb 25, 2026 23:43 pm UTC| Politics Health Law
Two Democratic state attorneys general have launched a multistate lawsuit against the Trump administration, challenging recent changes to the federal childhood vaccine schedule that public health experts warn could reduce...

Novo Nordisk Shares Tumble After CagriSema Misses Key Trial Endpoint
Feb 23, 2026 10:39 am UTC| Business Health
Novo Nordisk shares plunged more than 10% in mid-morning trading in Copenhagen on Monday after the pharmaceutical giant announced that its experimental obesity drug, CagriSema, failed to meet a primary endpoint in a...